Basit öğe kaydını göster

dc.contributor.authorBilici, Ahmet
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorGürsoy, Pınar
dc.contributor.authorÇubukçu, Erdem
dc.contributor.authorYıldız, Özcan
dc.contributor.authorSakın, Abdullah
dc.contributor.authorKorkmaz, Taner
dc.contributor.authorÇil, İbrahim
dc.contributor.authorÇakar, Beyhan
dc.contributor.authorMenekşe, Serkan
dc.contributor.authorDemir, Tarık
dc.contributor.authorAçıkgöz, Özgen
dc.contributor.authorHamdard, Jamshid
dc.date.accessioned2019-12-24T12:53:51Z
dc.date.available2019-12-24T12:53:51Z
dc.date.issued2019en_US
dc.identifier.citationBilici, A., Ölmez, Ö. F., Gürsoy, P., Çubukçu, E., Yıldız, Ö., Sakın, A. ... Hamdard, J. (2019). Systemic inflammatory markers as a predictors of response to crizotinib in patients with ALK-positive non-small-cell lung cancer. Journal of Thoracic Oncology içinde (S664-S665. ss.). https://doi.org/10.1016/j.jtho.2019.08.1407en_US
dc.identifier.issn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://doi.org/10.1016/j.jtho.2019.08.1407
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4653
dc.description.abstractThe significance of the presence of a systemic inflammatory response (SIR) in predicting survival has been demonstrated in patients with cancer. Moreover, neutrophil-to-lymphocyte ratio (NLR), lymphocyteratio (NLR), lymphocyte-to-monocyte ratio (LMR) and platelet-to-lymphocyte ratio (PLR) have been also investigated in patients with both early and advanced non-small-cell lung cancer (NSCLC). However, determination of SIR predicting outcomes of patients who are likely to response to crizotinib in ALK-positive NSCLC patients has not been clearly demonstrated.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectSystemic Inflammatoryen_US
dc.subjectALK-Positiveen_US
dc.subjectCellen_US
dc.subjectCrizotiniben_US
dc.titleSystemic inflammatory markers as a predictors of response to crizotinib in patients with ALK-positive non-small-cell lung canceren_US
dc.typeconferenceObjecten_US
dc.relation.ispartofJournal of Thoracic Oncologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume14en_US
dc.identifier.issue10en_US
dc.identifier.startpageS664en_US
dc.identifier.endpageS665en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.jtho.2019.08.1407en_US
dc.identifier.wosqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster